Two Sigma Advisers’s XBiotech XBIT Stock Holding History

Two Sigma Advisers’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,300	Closed	-$39K	–	2185
2025 Q4	$39K	Hold	16,300	–	–	﹤0.01%	2292
2025 Q3	$43.4K	Hold	16,300	–	–	﹤0.01%	2276
2025 Q2	$48.4K	Sell	16,300 -1,100	-6%	-$3.2K	﹤0.01%	2255
2025 Q1	$56.4K	Buy	+17,400	New	+$60K	﹤0.01%	2311
2024 Q2	–	Sell	-18,433	Closed	-$150K	–	2695
2024 Q1	$150K	Sell	18,433 -5,567	-23%	-$31.9K	﹤0.01%	2261
2023 Q4	$96K	Sell	24,000 -5,200	-18%	-$20.7K	﹤0.01%	2330
2023 Q3	$120K	Sell	29,200 -16,200	-36%	-$81.1K	﹤0.01%	2185
2023 Q2	$270K	Sell	45,400 -2,500	-5%	-$11.3K	﹤0.01%	2013
2023 Q1	$165K	Sell	47,900 -11,700	-20%	-$43.6K	﹤0.01%	2305
2022 Q4	$209K	Sell	59,600 -9,700	-14%	-$33.1K	﹤0.01%	2173
2022 Q3	$251K	Buy	69,300 +37,500	+118%	+$177K	﹤0.01%	2129
2022 Q2	$179K	Buy	+31,800	New	+$214K	﹤0.01%	2302

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's XBIT Position: Q1 2026 in Review

Two Sigma Advisers sold out of XBiotech (XBIT) in Q1 2026, closing a stake of 16,300 shares — an estimated $39K sold.

Two Sigma Advisers first reported a position in XBIT in Q2 2022 and held it in 12 quarters. The position peaked at $270K in Q2 2023. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

Two Sigma Advisers reported no remaining XBiotech position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 16,300 XBiotech shares in Q1 2026, an estimated $39K.
Two Sigma Advisers first reported a position in XBiotech in Q2 2022 and held it in 12 quarters.
Two Sigma Advisers's XBiotech position peaked at $270K in Q2 2023.
37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.